EGFR drugs for Head and Neck Squamous Cell Carcinoma
2 tracked EGFR drugs in the Head and Neck Squamous Cell Carcinoma race. The class explanation lives on the EGFR page; the full indication pipeline across every mechanism is on the Head and Neck Squamous Cell Carcinoma page.
1 approved / phase 41 Phase 3
Head-to-head evidence: Cetuximab vs CPO301